Learn More
Learn More
Learn More
Learn More
Learn More
In the past decade, drug discovery has focused on developing biologics. In particular, antibody therapeutics have been proven to be clinically effective for disease areas such as oncology and immunology.
07-28-2015 Frank Fan, M.D.Ph.D.
Conducting research in cancer therapeutics? Have you considered using cell/tumor penetrating peptides?
07-21-2015 James Mixson, University of Maryland, School of Medicine
This webinar will provide practical guidance for choosing the optimal protein or peptide immunogen for antibody production.
06-11-2015 LiYan Pang, Ph.D.
Is your antibody design strategy becoming a bottleneck in achieving high levels of recombinant antibody expression?
05-20-2015 Hangxing Yu, Ph.D.
Have you tried to make an antibody yet? Antibodies have become integral biochemical research tools and recently have emerged as their own class of biologic therapeutics.
05-10-2015 Glen Marszalowicz, Ph.D.
Does you research involve peptides, and do you often find yourself purchasing different combinations over and over for your experiments?
05-05-2015 Laura Genus, Ph.D.